Healthcare · NIFTY 500
Anthem Biosciences Limited
NSEANTHEM
BSE544449 ISININE0CZ201020 SeriesEQ Listed on NSE · BSE
₹938.45 -19.05 (-1.99%) Updated 12 Nov, 8:49 pm IST
Price, daily close+30.30% in a year
Today
- Open
- ₹957.00
- Prev close
- ₹957.50
- Day high
- ₹963.75
- Day low
- ₹931.00
- Volume
- 3.55 L
- Value traded
- ₹33.44 Cr
- Upper circuit
- ₹1,149.00
- Lower circuit
- ₹766.00
- 52W high
- ₹977.55
- 52W low
- ₹579.15
- 1 month
- +4.87%
- 6 months
- +16.68%
52W low52W high
Ratios
Key numbers
Worked out from the latest filings (Consolidated) and today's price. TTM = last four quarters.
Market cap₹52,884 Cr
P/E (TTM)86.81
P/B16.12
Book value / share₹58.22
EPS (TTM)₹10.81
ROE5.8%
Dividend yield0.21%
Dividend (12m)₹2.00 / share
Net margin (TTM)9.3%
Operating margin45.7%
Debt / equity0.01
Current ratio5.53
EV / EBITDA64.35
Sales growth (YoY qtr)+8.00%
Profit growth (YoY qtr)—
Sales CAGR 3Y—
Profit CAGR 3Y—
Shares56.35 Cr
Quarterly results
Results for each quarter
Last 6 quarters, consolidated, ₹ crore. Hover a bar to see the number.
Revenue and net profit
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
Revenue · QoQ (vs last quarter)
—+1.8%-23%+44%-32%+42%
Revenue · YoY (vs a year ago)
————-23%+8.0%
Net profit · QoQ (vs last quarter)
————-100%—
RevenueNet profitLine = trend
Jun 25
Sep 25
Dec 25
Mar 26
Jun 26
Sep 26
EPS (₹) · YoY (vs a year ago)
————-13%+22%
EPS (₹)Line = trend
| ₹ Cr | Jun 25 | Sep 25 | Dec 25 | Mar 26 | Jun 26 | Sep 26 |
|---|---|---|---|---|---|---|
| Revenue | 540 | 550 | 423 | 611 | 418 | 594 |
| Other income | 22.8 | 48.2 | 33.5 | 51.2 | 24.9 | 58.9 |
| Total income | 563 | 598 | 457 | 662 | 443 | 653 |
| Raw material | 162 | 201 | 185 | 165 | 149 | 201 |
| Purchases | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Employee cost | 72.0 | 67.7 | 70.5 | 72.5 | 78.8 | 81.3 |
| Other expenses | 45.8 | 41.0 | 52.9 | 55.8 | 42.6 | 56.6 |
| Total expenses | 377 | 369 | 301 | 385 | 299 | 357 |
| Operating profit | 191 | 218 | 132 | 268 | 151 | 271 |
| OPM % | 35.4% | 39.6% | 31.2% | 43.9% | 36.0% | 45.7% |
| Finance cost | 1.6 | 3.0 | 0.4 | 1.9 | 0.9 | 3.3 |
| Depreciation | 26.4 | 33.5 | 34.5 | 39.6 | 30.0 | 30.7 |
| Exceptional items | — | — | -25.4 | 1.0 | — | — |
| Profit before tax | 186 | 230 | 130 | 278 | 145 | 296 |
| Tax | 50.5 | 56.2 | 37.7 | 88.2 | 24.6 | 84.9 |
| Net profit | 136 | 173 | 92.8 | 190 | 120 | 211 |
| Profit to shareholders | 0.0 | 0.0 | 0.0 | — | 0.0 | 0.0 |
| EPS (₹) | 2.42 | 3.06 | 1.64 | 3.34 | 2.11 | 3.72 |
Profit & loss
Results for each year
1 financial years (April to March), consolidated, ₹ crore.
Sales, operating profit and net profit
FY26
RevenueOperating profitNet profitLine = trend
| ₹ Cr | FY26 |
|---|---|
| Revenue | 2,124 |
| Other income | 156 |
| Total expenses | 1,431 |
| Employee cost | 283 |
| Operating profit | 809 |
| OPM % | 38.1% |
| Finance cost | 6.9 |
| Depreciation | 134 |
| Profit before tax | 824 |
| Tax | 232 |
| Tax rate % | 28.2% |
| Net profit | 592 |
| Net margin % | 27.9% |
| EPS (₹) | 10.43 |
Balance sheet
Assets and debt
At each year end (and the latest half year), ₹ crore.
Equity, debt and assets
Mar 26
Sep 26
Shareholders' equityBorrowingsCashLine = trend
| ₹ Cr | Mar 26 | Sep 26 |
|---|---|---|
| Shareholders' equity | 3,043 | 3,281 |
| Long-term borrowings | 27.7 | 19.7 |
| Short-term borrowings | 23.3 | 19.0 |
| Total borrowings | 51.1 | 38.7 |
| Current liabilities | 326 | 340 |
| Fixed assets (PPE) | 780 | 765 |
| Inventories | 125 | 189 |
| Trade receivables | 591 | 527 |
| Cash & equivalents | 273 | 20.0 |
| Current assets | 1,803 | 1,881 |
| Total assets | 3,429 | 3,686 |
| Debt / equity | 0.02 | 0.01 |
Cash flow
Cash coming in and going out
For each financial year, ₹ crore. Free cash flow = cash from operations minus spending on fixed assets.
Operating, investing and financing cash
FY26
OperationsInvestingFinancingLine = trend
| ₹ Cr | FY26 |
|---|---|
| Cash from operations | 844 |
| Cash from investing | -702 |
| Cash from financing | -40.0 |
| Spent on fixed assets | -211 |
| Free cash flow | 633 |
| Net cash flow | 103 |
Shareholding
Who holds the shares
Promoter and public holding at each quarter end, as filed with NSE.
Holding over time
Promoter & groupPublic
Latest (30 Sep 2026)
71.4%promoter
- Promoter & group
- 71.40%
- Public (FIIs, mutual funds, retail…)
- 28.60%
- Promoter change, last quarter
- -0.02 pts
Dividends & news
Latest dividends and announcements
Dividends & corporate actions
- Dividend - Rs 2 Per Share
Board meetings
- the financial results for the period ended September 30, 2026
- Anthem Biosciences Limited has informed the Exchange about Board Meeting to be held on 03-Nov-2026 to inter-alia consider and approve the Unaudited F…
- the financial results for the period ended Jun 30, 2026
- Anthem Biosciences Limited has informed the Exchange about Board Meeting to be held on 21-Jul-2026 to inter-alia consider and approve the Unaudited F…
- the financial results for the period ended March 31, 2026 and dividend
Filings with NSE
- Analysts/Institutional Investor Meet/Con. Call Updates
- Analysts/Institutional Investor Meet/Con. Call Updates
- Analysts/Institutional Investor Meet/Con. Call Updates
- Copy of Newspaper Publication
- Investor Presentation
- Press Release
- Outcome of Board Meeting
Latest news
Anthem Biosciences share price: Why the stock has stalledValue Research · 29 Jul, 12:30 pmSociete General, Prudential, others buy 3 pc stake in Anthem Biosciences for Rs 1,275 crbfsi.economictimes.indiatimes.com · 19 Jun, 12:30 pmAnthem Biosciences Shares Rise 2.20% to Rs 859.50Moneycontrol.com · 10 Aug, 12:30 pmANTHEM Forecast — Price Target — Prediction for 2027TradingView · 25 Jun, 8:34 pmANTHEM BIOSCIENCES LTD Share PriceUpstox · 5 May, 5:06 pmAnthem Biosciences Q1 Results: Shares fall over 7% as delayed deliveries drag earningsCNBC TV18 · 22 Jul, 12:30 pmAnthem BioSciences shares jump 4% as Citi initiates with Buy rating. Check target, upside potentialThe Economic Times · 21 Apr, 12:30 pmAnthem Biosciences Share Price: Buy or SellUnivest · 7 Sep, 12:30 pmAbout
About Anthem Biosciences Limited
Anthem Biosciences Limited is listed on the NSE under the symbol ANTHEM and belongs to the Healthcare sector.
Company details
- Company name
- Anthem Biosciences Limited
- NSE symbol
- ANTHEM
- BSE scrip code
- 544449
- ISIN
- INE0CZ201020
- Listed on
- NSE, BSE
- Series
- EQ (normal equity)
- Listed on NSE since
- 21 Jul 2025
- Face value
- ₹2 per share
- Market lot
- 1 share
- Shares issued
- 56.35 crore
- Index
- NIFTY 500
- Sector (NSE)
- Healthcare
- Financial year
- April to March
- Results basis
- Consolidated
Peers
Other Healthcare stocks
-
DIVISLABDivi's Laboratories
₹11,485.00
+1.04%
-
ALKEMAlkem Laboratories
₹5,302.00
-2.68%
-
GRANULESGranules India
₹840.50
+5.16%
-
SUNPHARMASun Pharmaceutical Industries
₹1,885.00
-0.91%
-
LAURUSLABSLaurus Labs
₹2,400.00
-1.19%
-
AUROPHARMAAurobindo Pharma
₹1,807.20
-1.11%
-
ACUTAASAcutaas Chemicals
₹3,996.10
+2.02%
-
APOLLOHOSPApollo Hospitals Enterprise
₹8,515.00
-1.03%
Prices from NSE via Upstox. Financials from the company's results filed with NSE (XBRL); ratios are our own working. Profile from global-stock-logos (MIT). For information only, not a recommendation to buy or sell.